Dr. Martens PLCLSE: DOCS

Dr. Martens: Director/PDMR Shareholding

· Issued by Dr. Martens PLC via RNS

Summary by 6ix AI

Dr. Martens plc said Chief Executive Officer Ije Nwokorie and Chief Financial Officer Giles Wilson bought shares at 68 pence each on October 12, 2026 through the company's Share Incentive Plan, an all-employee scheme, and were awarded an equal number of free matching shares.

Key details

  • Ije Nwokorie bought 220 Partnership Shares (shares bought from monthly salary) and was awarded 220 Matching Shares at no cost.
  • Giles Wilson bought 221 Partnership Shares and was awarded 221 Matching Shares at no cost.
  • Under the plan, which is approved by HMRC (the UK tax authority), employees receive one free Matching Share for every Partnership Share they buy.
  • The Partnership Shares were bought on the London Stock Exchange; the Matching Shares were awarded outside a trading venue. The company was notified of the transactions on October 13, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/directorpdmr-shareholding-1597

Watch Dr. Martens' latest callDr. Martens (LSE:DOCS) Q4 2026 Earnings Call · Replay · May 19Read the transcript of Dr. Martens (LSE:DOCS) Q4 2026 Earnings Call

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it was notified on 13 October 2026 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').

The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.

On 12 October 2026, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 68 pence per share and were granted an allocation of Matching Shares (for no consideration) in the quantity set out in the table below:

Director / PDMR

Number of Partnership Shares purchased

Number of
Matching Shares awarded

Ije Nwokorie

220

220

Giles Wilson

221

221


The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ije Nwokorie

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01


ISIN: GB00BL6NGV24

b)

Nature of the transaction

1.     Purchase of Partnership Shares under the SIP

2.     Award of Matching Shares under the SIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.

68p

220

2.

Nil

220

d)

Aggregated information

-

Aggregated volume

-

Price

-

Aggregated volume

-

Price

1.

Partnership shares

220

68p

2.

Matching shares

220

Nil

e)

Date of the transaction

12 October 2026

f)

Place of the transaction

1.     London Stock Exchange (XLON)

2.     Outside of a trading venue

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Giles Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01


ISIN: GB00BL6NGV24

b)

Nature of the transaction

1.     Purchase of Partnership Shares under the SIP

2.     Award of Matching Shares under the SIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.

68p

221

2.

Nil

221

d)

Aggregated information

-

Aggregated volume

-

Price

-

Aggregated volume

-

Price

1.

Partnership shares

221

68p

2.

Matching shares

221

Nil

e)

Date of the transaction

12 October 2026

f)

Place of the transaction

1.     London Stock Exchange (XLON)

2.     Outside of a trading venue

For further information please contact:

Zhwan Woof

Company Secretarial

+44(0)7585 3982165

Dr. Martens PLC on 6ix

Earlier from Dr. Martens

All Dr. Martens news releases